Cargando…

Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype

Objective: To investigate the effect of telmisartan, rosuvastatin, or their combination on dementia and to understand the impact of apolipoprotein E (APOE) genotype on the effect of the medications in older patients with hypertension. Methods: This is a double-blind, randomized, and placebo-controll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wenjing, Li, Ying, Zhao, Yingxin, Dong, Yuanli, Cui, Yi, Sun, Shangwen, Gong, Gary, Zhang, Hua, Chai, Qiang, Wang, Juan, Liu, Zhendong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296075/ https://www.ncbi.nlm.nih.gov/pubmed/32581766 http://dx.doi.org/10.3389/fnagi.2020.00154

Ejemplares similares

Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice
por: Liu, Hongyang, et al.
Publicado: (2020)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
por: Choi, JungMin, et al.
Publicado: (2021)

Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells
por: Steinmetz, Martin, et al.
Publicado: (2010)

Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2019)

Effects of Rosuvastatin on Apolipoprotein J in Balloon-Injured Carotid Artery in Rats
por: Yang, Ning, et al.
Publicado: (2018)

Attenuating the Variability of Lipids Is Beneficial for the Hypertension Management to Reduce the Cardiovascular Morbidity and Mortality in Older Adults
por: Dong, Yuanli, et al.
Publicado: (2021)

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
por: Yuan, Tao, et al.
Publicado: (2023)

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021)

Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial
por: Song, Zhao-Yan, et al.
Publicado: (2023)

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008)

Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study
por: Liu, Chi-Hung, et al.
Publicado: (2021)

Utilizing apolipoprotein E genotypes and associated comorbidities for the assessment of the risk for dementia
por: Tung, Hsin, et al.
Publicado: (2022)

Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age
por: Guo, Yuqi, et al.
Publicado: (2020)

Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial
por: Camilleri, Eleonora, et al.
Publicado: (2023)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)

New standards in hypertension and cardiovascular risk management: focus on telmisartan
por: Galzerano, Domenico, et al.
Publicado: (2010)

Clinical data analysis of telmisartan for hypertension management in Indian population
por: Prem Kumar, A, et al.
Publicado: (2021)

Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
por: Cheng, Kai-Chun, et al.
Publicado: (2018)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Low carotid wall shear stress independently accelerates the progression of cognitive impairment and white matter lesions in the elderly
por: Zhang, Hua, et al.
Publicado: (2017)

Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1
por: Shang, Peijin, et al.
Publicado: (2017)

Hypertension and microalbuminuria in HIV infected patients: beneficial effects of the treatment with telmisartan
por: Ucciferri, Claudio, et al.
Publicado: (2010)

The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension
por: Jung, An Doc, et al.
Publicado: (2009)

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
por: Park, Jung Gyu, et al.
Publicado: (2019)

Interaction between apolipoprotein E genotype and hypertension on cognitive function in older women in the Nurses’ Health Study
por: Kim, Iris Y., et al.
Publicado: (2019)

Empty-nest-related psychological distress is associated with progression of brain white matter lesions and cognitive impairment in the elderly
por: Duan, Dandan, et al.
Publicado: (2017)

Rosuvastatin Synergistically Enhances the Antinociceptive Efficacy of Duloxetine in Paclitaxel-Induced Neuropathic Pain in Mice
por: Lobos, Nicolás, et al.
Publicado: (2023)

Apolipoprotein E4 Genotype and Depressive Symptoms as Risk Factors for Dementia in an Older Korean Population
por: Kim, Jae-Min, et al.
Publicado: (2010)

Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
por: Maillard, Marc P, et al.
Publicado: (2007)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Saha, Lekha
Publicado: (2011)

Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension
por: Bekki, Hisatoshi, et al.
Publicado: (2010)

Telmisartan Versus Valsartan in Patients With Hypertension: Effects on Cardiovascular, Metabolic, and Inflammatory Parameters
por: Lim, Sung Yoon, et al.
Publicado: (2011)

Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension
por: Shimizu, Yuji, et al.
Publicado: (2012)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Akat, Pramod B., et al.
Publicado: (2010)

The effects of telmisartan on the nuclear factor of activated T lymphocytes signalling pathway in hypertensive patients
por: Huang, Sha-Sha, et al.
Publicado: (2016)

Improving hypertension control in patients at cardiovascular risk: the case for telmisartan-based therapy
por: J, Aalbers
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1f3uhdkkn7r6nvil2h7qkp5f94